About the Study
What is the REACH Project?
A genetic study that is being carried out by researchers from the UCSD Department of Psychiatry and Rady Children's Hospital.
What is the goal of the REACH Project?
The goal of this study is to to identify the genetic causes of neurodevelopmental disorders and to obtain an improved understanding of the effects of these variants on the brain.
Why is the focus of the REACH Project important?
Previous studies by our group have discovered that certain genetic variations confer significant risk for autism and other neurodevelopmental disorders. However, relatively little is known about how these genes impact the brain. We believe that a deeper understanding of the underlying genetics and neurobiology will lead to the development of new treatments for these disorders.
Why participate in the REACH Project?
Our continued success depends on the participation of patients and their families. Enrolling a large number participants with a wide spectrum of neurodevelopmental conditions will give us the greatest chance of identifying important genes.
Who can participate?
Any child or adolescent between 3 and 17 years of age who has experienced developmental, medical, neurological, and/or mental health issues for which she or he has been evaluated or treated for.
Children and adolescents with any of the following conditions are eligible to participate: autism, ADHD, anxiety disorders, psychiatric disorders, depression and mood disorders, learning disabilities, speech and language delays, brain abnormalities, or epilepsy. A formal diagnosis is not necessary for participation, as long as the child or adolescent has been or is currently being evaluated or treated for a developmental condition. Children and adolescents with known genetic conditions are also encouraged to participate.
What information will you share with me?
Although the genetic analysis inherent to this study is for research purposes, occasionally a disease-associated mutation will be detected in the DNA sample of study participants. If such a mutation is identified in your child, then with your permission, you will be contacted. Only with your written consent, will we share these findings with your child's primary care physician. Your child's physician can share and interpret the results for you. A consultation with a clinical geneticist, free of charge, will be offered to your primary care physician in this case.
How do I get involved?
You can contact us at any time by phone or email to enroll in the study or for any information, without obligation to participate. Appointments can be scheduled for immediate participation or at more convenient times in the near future.
You may also complete this Permission to Contact form if you wish to be contacted with more information. Click Here
Who do I contact for more information?
Call our study coordinator: (858) 576-1700 x3638